Published on in Vol 9, No 2 (2022): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/26825, first published .
Proposal for Post Hoc Quality Control in Instrumented Motion Analysis Using Markerless Motion Capture: Development and Usability Study

Proposal for Post Hoc Quality Control in Instrumented Motion Analysis Using Markerless Motion Capture: Development and Usability Study

Proposal for Post Hoc Quality Control in Instrumented Motion Analysis Using Markerless Motion Capture: Development and Usability Study

Hanna Marie Röhling   1, 2, 3, 4 , MSc ;   Patrik Althoff   1, 2, 3 ;   Radina Arsenova   1, 2, 3, 5 , MD ;   Daniel Drebinger   1, 2, 3 ;   Norman Gigengack   1, 2, 3 ;   Anna Chorschew   1, 2, 3 ;   Daniel Kroneberg   6 , MD ;   Maria Rönnefarth   6, 7 , MD ;   Tobias Ellermeyer   1, 2, 3, 8 ;   Sina Cathérine Rosenkranz   9, 10 , MD ;   Christoph Heesen   9, 10 , MD ;   Behnoush Behnia   11 , MD ;   Shigeki Hirano   12 , MD, PhD ;   Satoshi Kuwabara   12 , MD, PhD ;   Friedemann Paul   1, 2, 3, 6, 13 , MD ;   Alexander Ulrich Brandt   13, 14 , MD ;   Tanja Schmitz-Hübsch   1, 2, 3, 13 , MD

1 Experimental and Clinical Research Center, a cooperation between the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, Germany

2 Experimental and Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

3 Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany

4 Motognosis GmbH, Berlin, Germany

5 Department of Pediatrics, St Joseph Krankenhaus Berlin-Tempelhof, Berlin, Germany

6 Department of Neurology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

7 Clinical Study Center, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany

8 Department of Neurology, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany

9 Institute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany

10 Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

11 Department of Psychiatry, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

12 Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan

13 NeuroCure Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

14 Department of Neurology, University of California, Irvine, CA, United States

Corresponding Author:

  • Hanna Marie Röhling, MSc
  • Experimental and Clinical Research Center, a cooperation between the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin
  • Lindenberger Weg 80
  • Berlin, 13125
  • Germany
  • Phone: 49 30-450539718
  • Fax: 49 30-450-539915
  • Email: hanna-marie.roehling@charite.de